Self-collected samples to test for cervical cancer are a step in the right direction when it comes to addressing healthcare ...

Tylenol and autism, the Inflation Reduction Act, the One Big Beautiful Bill, Most Favored Nation pricing and direct drug ...

Libtayo's approval for high-risk cutaneous squamous cell carcinoma offers a new immunotherapy option, targeting PD-1 ...

Transparency, prior authorization, PBM reform and PBM offered genomics testing are some the trends Formulary Watched tracked ...

Each Sunday we feature a highlight reel of various articles posted on our website that week.

The FDA warned against unapproved sunscreen forms, while Australian tests exposed inaccurate SPF claims, causing consumer ...

Renuka Iyer, M.D., will assume the role of CMO at NCCN, focusing on advancing evidence-based cancer care and guideline ...

New drug prices increased by 51% over three years, often exceeding value benchmarks, potentially costing the healthcare system $1.5 billion. Providers worry about medication stocking due to Part B ...

Now there is evidence that Hympavzi is also effective for people with hemophilia A and B who have developed inhibitors, a ...

However, one significant problem has proven surprisingly durable: misdiagnosis of Type 1 diabetes (T1D). Estimates suggest ...

A new influenza strain could fuel a severe flu season while a surge in measles cases threatens U.S. elimination status, ...

A final discussion point is real-world applicability. Although PHAROS presents exceptional PFS, the modest difference between ...